CTI BIOPHARMA CORP's ticker is CTICXXXX and the CUSIP is 12648L106. A total of 63 filers reported holding CTI BIOPHARMA CORP in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.1%.
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BVF INC/IL | 44,796,940 | $23,805,000 | 5.89% |
Stonepine Capital Management, LLC | 3,743,340 | $1,989,000 | 2.35% |
Bayesian Capital Management, LP | 76,100 | $40,000 | 0.04% |
JW Asset Management, LLC | 50,254 | $27,000 | 0.02% |
WASHINGTON TRUST Co | 410,616 | $218,000 | 0.02% |
Modera Wealth Management, LLC | 25,000 | $13,000 | 0.01% |
Alyeska Investment Group, L.P. | 773,469 | $411,000 | 0.00% |
First Heartland Consultants, Inc. | 14,924 | $8,000 | 0.00% |
UNITED CAPITAL FINANCIAL ADVISORS, LLC | 526,210 | $279,000 | 0.00% |
TUDOR INVESTMENT CORP ET AL | 188,500 | $100,000 | 0.00% |